131 related articles for article (PubMed ID: 1904114)
21. Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice.
Irifune M; Shimizu T; Nomoto M
Pharmacol Biochem Behav; 1991 Oct; 40(2):399-407. PubMed ID: 1805243
[TBL] [Abstract][Full Text] [Related]
22. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
Koob GF; Simon H; Herman JP; Le Moal M
Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
[TBL] [Abstract][Full Text] [Related]
23. Central dopaminergic actions of YM-14673, a new TRH analogue, in rodents.
Yamamoto M; Ozawa Y; Sasamata M; Koshikawa N; Kobayashi M
Eur J Pharmacol; 1990 May; 180(2-3):319-24. PubMed ID: 1973117
[TBL] [Abstract][Full Text] [Related]
24. Role of the ventromedial nucleus of the thalamus in motor behaviour--II. Effects of lesions.
Starr MS; Summerhayes M
Neuroscience; 1983 Dec; 10(4):1171-83. PubMed ID: 6320047
[TBL] [Abstract][Full Text] [Related]
25. Estradiol, TRH and striatal dopaminergic mechanisms.
Bédard PJ; Malouin F; Dipaolo T; Labrie F
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):555-61. PubMed ID: 6819600
[TBL] [Abstract][Full Text] [Related]
26. Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens.
Pinnock RD; Woodruff GN; Turnbull MJ
Neuropharmacology; 1983 Jun; 22(6):687-96. PubMed ID: 6193454
[TBL] [Abstract][Full Text] [Related]
27. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
Sivam SP
Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
[TBL] [Abstract][Full Text] [Related]
28. Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain.
Yoshida M; Torigoe R; Ohtsuru K; Kuramoto S
Stereotact Funct Neurosurg; 1990; 54-55():342-6. PubMed ID: 2127860
[TBL] [Abstract][Full Text] [Related]
29. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
[TBL] [Abstract][Full Text] [Related]
30. Possible involvement of nigrostriatal dopamine system in the inhibition of thyrotropin secretion in the rat.
Männistö P; Mattila J; Kaakkola S
Eur J Pharmacol; 1981 Dec; 76(4):403-9. PubMed ID: 6799305
[TBL] [Abstract][Full Text] [Related]
31. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
[TBL] [Abstract][Full Text] [Related]
32. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
33. Opposite effects of intranigral ibotenic acid and 6-hydroxydopamine on motor behavior and on striatal neuropeptide Y neurons.
Nitsch C; Wolfrum G; Schaefer F; Scotti AL; Unger J
Brain Res Bull; 1993; 30(1-2):21-32. PubMed ID: 8420631
[TBL] [Abstract][Full Text] [Related]
34. Lithium-induced polydipsia: dependence on nigrostriatal dopamine pathway and relationship to changes in the renin-angiotensin system.
Mailman RB
Psychopharmacology (Berl); 1983; 80(2):143-9. PubMed ID: 6410443
[TBL] [Abstract][Full Text] [Related]
35. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus.
Swerdlow NR; Amalric M; Koob GF
Pharmacol Biochem Behav; 1987 Apr; 26(4):765-9. PubMed ID: 3110795
[TBL] [Abstract][Full Text] [Related]
36. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
[TBL] [Abstract][Full Text] [Related]
37. Effect of DN-1417, a thyrotropin releasing hormone analog, on dopaminergic neurons in rat brain.
Nakahara T; Matsumoto T; Hirano M; Uchimura H; Yokoo H; Nakamura K; Ishibashi K; Hirano H
Peptides; 1985; 6(6):1093-9. PubMed ID: 3938840
[TBL] [Abstract][Full Text] [Related]
38. Apomorphine induces latent rotation in lesioned rats, amphetamine does not.
Silverman PB
Life Sci; 1988; 42(23):2397-401. PubMed ID: 3131609
[TBL] [Abstract][Full Text] [Related]
39. Circling behavior following unilateral kainic acid injections into rat striatum.
Taylor RJ; Reavill C; Jenner P; Marsden CD
Eur J Pharmacol; 1981 Dec; 76(2-3):211-22. PubMed ID: 7333356
[TBL] [Abstract][Full Text] [Related]
40. Intrastriatal angiotensin II induces turning behaviour in 6-hydroxydopamine lesioned rats.
Jenkins TA; Chai SY; Howells DW; Mendelsohn FA
Brain Res; 1995 Sep; 691(1-2):213-6. PubMed ID: 8590055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
